HealthQuill Migraine
Akebia Therapeutics, a US Massachusetts-based biotechnology company, has got the regulator’s approval for its Vafseo drug to treat anaemia in patients undergoing dialysis for at least three months.
Drugs Health Medical

Preoperative botox jabs may help identify migraine trigger sites

HQ Team May 10, 2024: Botox has been traditionally used to treat migraine, but there is not enough data available to prove its.

Read More
Pfizer announced the availability of its migraine management drug Rimegepant in Hong Kong — the company’s first market in Asia.
Drugs Health Pharma

Pfizer enters Hong Kong migraine market, its first in Asia

HQ Team September 29, 2023: Pfizer announced the availability of its migraine management drug Rimegepant in Hong Kong — the company’s first market.

Read More